Lipids

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B
Lancet. 2011 Jun 25;377(9784):2181-92
Google Plus
LinkedIn

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V
N Engl J Med. 2009 Apr 2;360(14):1395-407
Google Plus
LinkedIn

Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis

Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz E; German Diabetes and Dialysis Study Investigators
N Engl J Med. 2005 Jul 21;353(3):238-48
Google Plus
LinkedIn

ukidneyisup